早产儿视网膜血管完全化速率、时间及相关因素
一项单中心回顾性队列研究纳入2016年7月至2019年6月期间接受早产儿视网膜病变(ROP)筛查的541例早产儿,分析视网膜血管完全化的比例、时间及相关因素。结果显示439例(89.59%)实现血管完全化,平均矫正胎龄45.39±11.04周,95.22%在64周前完成;低出生体重预测血管完全化延迟,ROP存在及抗血管内皮生长因子治疗也可能影响血管完全化时间。
要点
- 541例筛查婴儿中490例有完整记录,439例(89.59%)实现视网膜血管完全化,平均矫正胎龄45.39±11.04周。
- 95.22%的婴儿在矫正胎龄64周前完成血管完全化。
- 无ROP、未治疗ROP和治疗ROP三组血管完全化率分别为99.7%、66.2%和16.7%,差异有统计学意义。
核心结论
- 低出生体重预测视网膜血管完全化延迟。
- 抗血管内皮生长因子治疗和ROP的存在(包括ROP严重程度)也可能影响血管完全化时间。
- 这些发现应有助于提高对早产儿持续性无血管视网膜的理解和管理。
研究设计与样本
- 单中心、回顾性队列研究,纳入2016年7月至2019年6月期间接受ROP筛查的541例早产儿。
- 患者定期接受散瞳间接检眼镜眼底检查直至血管完全化,取每位患者较差眼进行分析。
- 分析末次随访时视网膜血管完全化的婴儿比例及完全血管化时间。
主要发现
- 所有婴儿平均胎龄31.29±3.12周;490例(90.57%)有视网膜血管化结局完整记录,其中439例(89.59%)实现完全血管化。
- 完全血管化的平均矫正胎龄为45.39±11.04周,95.22%在矫正胎龄64周前完成。
- 118例(22.56%)发生ROP;33例(6.10%)接受抗血管内皮生长因子治疗。
- 对所有筛查婴儿,较低出生体重、ROP存在及抗血管内皮生长因子治疗预测完全血管化延迟;对确诊ROP的婴儿,仅较低出生体重预测完全血管化延迟。
- 亚组分析显示无ROP、未治疗ROP和治疗ROP三组间完全血管化时间及比率存在显著差异(分别为99.7%、66.2%和16.7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the rate of and time to complete vascularization in premature infants and to explore associated factors. METHODS: A monocentric, retrospective cohort study including 541 premature infants who underwent screening for retinopathy of prematurity (ROP) between July 2016 and June 2019. Patients underwent regular dilated fundus examinations with indirect ophthalmoscopy until complete vascularization. The worse eye of each patient was included for analyses. The proportion of infants with complete retinal vascularization at the last visit and the time to full vascularization was analyzed. RESULTS: Among all infants (average gestational age 31.29 ± 3.12 weeks), 490 (90.57%) had complete records of retinal vascularization outcomes, of whom 439 (89.59%) achieved complete vascularization. The average postmenstrual age for complete vascularization was 45.39 ± 11.04 weeks, and 95.22% achieved completion before 64 weeks of postmenstrual age. Retinopathy of prematurity developed in 118 (22.56%) infants; 33 (6.10%) received antivascular endothelial growth factor treatment. For all infants screened for ROP, lower birth weight, presence of ROP, and antivascular endothelial growth factor therapy predicted delayed complete vascularization; for infants diagnosed with ROP, only lower birth weight predicted delayed complete vascularization. Subgroup analysis showed significant differences between patients without ROP, with untreated ROP, and with treated ROP in time to complete vascularization and its rate (99.7%, 66.2%, and 16.7%, respectively). CONCLUSION: Lower birth weight predicted delayed complete vascularization. Antivascular endothelial growth factor therapy and the presence of ROP, including ROP severity, may also affect time to complete vascularization. These findings should help improve the understanding and management of persistent avascular retina in preterm infants.
引用
- Lai TT, Yang CM, Hsieh YT, et al. RATE OF AND TIME TO COMPLETE RETINAL VASCULARIZATION IN PREMATURE INFANTS AND ASSOCIATED FACTORS. Retina. 2023. PMID: 36201755. doi:10.1097/IAE.0000000000003627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。